Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jun;43(6):820-36.
doi: 10.2165/00003495-199243060-00003.

Appetite Suppressants. A Review


Appetite Suppressants. A Review

T Silverstone. Drugs. .


Centrally acting appetite suppressant drugs used in the treatment of obesity fall into 2 broad pharmacological categories; those which act via brain catecholamine pathways and those which act via serotonin pathways. Of the former group, amphetamine and phenmetrazine are no longer recommended because of their stimulant properties and addictive potential. The remaining drugs in this class include amfepramone (diethylpropion), phentermine, mazindol and phenylpropanolamine. All have been shown to reduce appetite and lower food intake, thereby helping obese patients more easily keep to a low-calorie diet and lose weight. They all have some sympathomimetic and stimulant properties. Anorectic drugs which promote serotonin neurotransmission have no such stimulant or sympathomimetic properties. They are fenfluramine, together with its recently introduced dextrorotatory stereoisomer dexfenfluramine, and fluoxetine. They reduce appetite and food intake and are effective in the treatment of obesity. Anorectic drugs should be reserved for those who are clinically at risk from being overweight, and then only as part of a comprehensive weight-reducing programme including regular dietary counselling. Although current licensing regulations only allow their use over a relatively short period (12 to 16 weeks), clinical trials have shown them to be effective over longer periods, particularly in preventing weight regain. Of the compounds currently indicated for use in obesity, dexfenfluramine appears to have the most suitable pharmacological profile, although it should not be given to patients with a history of depression. When used appropriately, appetite suppressants can be of real therapeutic benefit, and pose little risk.

Similar articles

See all similar articles

Cited by 22 articles

See all "Cited by" articles


    1. Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1073-77 - PubMed
    1. Int J Obes. 1978;2(2):167-89 - PubMed
    1. Br J Clin Pract. 1970 Oct;24(10):423-5 - PubMed
    1. Int J Obes. 1983;7(6):591-5 - PubMed
    1. J Clin Psychopharmacol. 1989 Feb;9(1):33-8 - PubMed

LinkOut - more resources